<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.palb2.org/wp-sitemap.xsl" ?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"><url><loc>https://www.palb2.org/implications-of-having-palb2-mutation/</loc><lastmod>2025-03-20T15:50:56+00:00</lastmod></url><url><loc>https://www.palb2.org/what-is-palb2-gene/</loc><lastmod>2025-03-20T15:50:56+00:00</lastmod></url><url><loc>https://www.palb2.org/help-us-to-learn-more-about-palb2-gene/</loc><lastmod>2025-03-20T15:50:56+00:00</lastmod></url><url><loc>https://www.palb2.org/we-appreciate-your-support/</loc><lastmod>2025-03-20T15:50:56+00:00</lastmod></url><url><loc>https://www.palb2.org/variant-of-unknown-significance/</loc><lastmod>2025-03-20T15:50:56+00:00</lastmod></url><url><loc>https://www.palb2.org/spotlight-dr-marc-tischkowitz/</loc><lastmod>2025-03-20T15:50:56+00:00</lastmod></url><url><loc>https://www.palb2.org/palb2-interest-group-update-april-2017/</loc><lastmod>2025-03-20T15:50:56+00:00</lastmod></url><url><loc>https://www.palb2.org/men-affected-breast-cancer-palb2-mutations/</loc><lastmod>2025-03-20T15:50:56+00:00</lastmod></url><url><loc>https://www.palb2.org/comprehensive-review-article-on-palb2-published-by/</loc><lastmod>2025-03-20T15:50:56+00:00</lastmod></url><url><loc>https://www.palb2.org/new-publication-from-the-interest-group-2019/</loc><lastmod>2025-03-20T15:50:56+00:00</lastmod></url><url><loc>https://www.palb2.org/palb2-information-session-24sep2020-recording-now-available/</loc><lastmod>2021-10-11T16:26:00+01:00</lastmod></url><url><loc>https://www.palb2.org/acmg-palb2-clinical-guidelines-now-available/</loc><lastmod>2025-03-20T15:50:56+00:00</lastmod></url><url><loc>https://www.palb2.org/a-story-on-palb2-in-the-new-york-times/</loc><lastmod>2025-03-20T15:50:56+00:00</lastmod></url><url><loc>https://www.palb2.org/breast-cancer-survivor-and-journalist-susan-berger-talks-about-her-experience-of-having-a-palb2-mutation/</loc><lastmod>2025-03-20T15:50:56+00:00</lastmod></url><url><loc>https://www.palb2.org/asco-post-commentary-on-the-palb2-acmg-management-guidelines/</loc><lastmod>2025-03-20T15:50:56+00:00</lastmod></url><url><loc>https://www.palb2.org/uk-palb2-carriers-information-session-4th-annual-event-16th-october-2024/</loc><lastmod>2025-03-24T08:40:06+00:00</lastmod></url><url><loc>https://www.palb2.org/palb2-carriers-information-session-5th-annual-event-3rd-december-2025-at-5-6pm/</loc><lastmod>2025-11-19T08:54:48+00:00</lastmod></url><url><loc>https://www.palb2.org/new-evidence-for-parpi-in-palb2-the-tbcrc-048-trial-led-by-dr-nadine-tung-evaluated-the-parp-inhibitor-olaparib-in-women-with-metastatic-breast-cancer-and-germline-palb2-mutation/</loc><lastmod>2026-03-07T21:10:43+00:00</lastmod></url><url><loc>https://www.palb2.org/palb2-at-20-should-we-now-call-it-brca3/</loc><lastmod>2026-03-13T22:57:50+00:00</lastmod></url><url><loc>https://www.palb2.org/goodbye-breasts/</loc><lastmod>2026-03-24T11:36:03+00:00</lastmod></url></urlset>
